These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 26015210)
21. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)]. Matzkies F; Berg G Dtsch Med Wochenschr; 1976 Oct; 101(43):1568-70. PubMed ID: 991731 [TBL] [Abstract][Full Text] [Related]
22. [The action of allopurinol on uric acid transport]. Koçak N; Tunali A; Ozdoğan E; Tuna S Turk Tip Cemiy Mecm; 1973 Jul; 39(7):264-69. PubMed ID: 4805462 [No Abstract] [Full Text] [Related]
23. [Drug therapy of hyperuricemia]. Gröbner W Verh Dtsch Ges Inn Med; 1986; 92():492-7. PubMed ID: 3811551 [No Abstract] [Full Text] [Related]
24. [Allopurinol in the treatment of hyperuricemia and chronic gout]. Benedetti A; Nardini A; Busonera G Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585 [No Abstract] [Full Text] [Related]
25. [Early diagnosis of gout]. Heidelmann G Z Arztl Fortbild (Jena); 1979 Jul; 73(13-14):683-4. PubMed ID: 506322 [No Abstract] [Full Text] [Related]
26. Febuxostat efficacy in allopurinol-resistant tophaceous gout. Uh M; Reid G J Clin Rheumatol; 2011 Jun; 17(4):204-6. PubMed ID: 21617552 [TBL] [Abstract][Full Text] [Related]
27. Hyperlipoproteinaemia in gout. Bluestone R; Lewis B; Mervart I Ann Rheum Dis; 1971 Mar; 30(2):134-7. PubMed ID: 5569433 [No Abstract] [Full Text] [Related]
28. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia. Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549 [TBL] [Abstract][Full Text] [Related]
29. Chronic gouty nephropathy treated by long-term hemodialysis and allopurinol. Johnson WJ; O'Duffy JD Mayo Clin Proc; 1979 Sep; 54(9):618-20. PubMed ID: 470461 [TBL] [Abstract][Full Text] [Related]
30. The use of allopurinol in controlling hyperuricemia. Streiker FB J Am Podiatry Assoc; 1969 Mar; 59(3):87-9. PubMed ID: 5775103 [No Abstract] [Full Text] [Related]
31. [Allopurinol in the treatment of gout]. Isomäki H; Kemilä S Duodecim; 1968; 84(17):975-80. PubMed ID: 5704850 [No Abstract] [Full Text] [Related]
32. [Therapeutic efficacy of slow-release allopurinol in gout and hyperuricaemia (author's transl)]. Dunky A; Nitsche V; Eberl R Wien Klin Wochenschr; 1981 Jan; 93(2):65-8. PubMed ID: 7245774 [TBL] [Abstract][Full Text] [Related]
33. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis. Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724 [TBL] [Abstract][Full Text] [Related]
34. Withdrawal of allopurinol in patients with gout. Scott JT; Loebl WY Adv Exp Med Biol; 1974; 41():577-9. PubMed ID: 4832584 [No Abstract] [Full Text] [Related]
35. [Allopurinol in the treatment of gout. Preliminary report]. Lignière GC; Cirla E Reumatismo; 1968; 20(2):101-3. PubMed ID: 5748155 [No Abstract] [Full Text] [Related]
36. [Medical control of uric acid in patients with gout--desirable level of serum uric acid and the choice of drugs]. Yamanaka H Nihon Rinsho; 1991 May; 49(5):1093-101. PubMed ID: 2067100 [No Abstract] [Full Text] [Related]
37. [Hyperuricemia/gout. Main symptoms of arthropathy. Severe acute joint pain, redness, inflammation]. Kolyvanos Naumann U; Suter PM; Käser L; Vetter W Praxis (Bern 1994); 2005 Apr; 94(14):543-8; quiz 549. PubMed ID: 15849976 [No Abstract] [Full Text] [Related]
38. [Allopurinol in the treatment of gout]. Sabah D Rev Med Chil; 1970; 98(9):622-7. PubMed ID: 5509800 [No Abstract] [Full Text] [Related]
39. [Allopurinol in the treatment of gout]. Klein G; Griendl W; Kalb R Z Rheumaforsch; 1968 Dec; 27(11):455-60. PubMed ID: 5710881 [No Abstract] [Full Text] [Related]
40. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study. Schumacher HR; Evans RR; Saag KG; Clower J; Jennings W; Weinstein SP; Yancopoulos GD; Wang J; Terkeltaub R Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1462-70. PubMed ID: 22549879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]